Tugtepe, H. Et Al. 2007. Oxidative renal damage in pyelonephritic rats is ameliorated by montelukast, a selective leukotriene CysLT1 receptor antagonist. EUROPEAN JOURNAL OF PHARMACOLOGY , vol.557, no.1 , 69-75.

Tugtepe, H., Sener, G., Cetinel, S., Velioglu-Ogunc, A., & Yegen, B., (2007). Oxidative renal damage in pyelonephritic rats is ameliorated by montelukast, a selective leukotriene CysLT1 receptor antagonist. EUROPEAN JOURNAL OF PHARMACOLOGY , vol.557, no.1, 69-75.

Tugtepe, Halil Et Al. "Oxidative renal damage in pyelonephritic rats is ameliorated by montelukast, a selective leukotriene CysLT1 receptor antagonist," EUROPEAN JOURNAL OF PHARMACOLOGY , vol.557, no.1, 69-75, 2007

Tugtepe, Halil Et Al. "Oxidative renal damage in pyelonephritic rats is ameliorated by montelukast, a selective leukotriene CysLT1 receptor antagonist." EUROPEAN JOURNAL OF PHARMACOLOGY , vol.557, no.1, pp.69-75, 2007

Tugtepe, H. Et Al. (2007) . "Oxidative renal damage in pyelonephritic rats is ameliorated by montelukast, a selective leukotriene CysLT1 receptor antagonist." EUROPEAN JOURNAL OF PHARMACOLOGY , vol.557, no.1, pp.69-75.

@article{article, author={Halil Tugtepe Et Al. }, title={Oxidative renal damage in pyelonephritic rats is ameliorated by montelukast, a selective leukotriene CysLT1 receptor antagonist}, journal={EUROPEAN JOURNAL OF PHARMACOLOGY}, year=2007, pages={69-75} }